Unbiased AI-powered news
2 stories related to this topic, newest first.
StatVertex Pharmaceuticals announced it will buy Crinetics Pharmaceuticals for $10 billion, or $85 per share. The transaction marks Vertex's largest acquisition and adds a commercial drug for acromegaly plus a late-stage candidate for congenital adrenal hyperplasia.
blog.googleGoogle has retired its Vertex AI platform and introduced the new Gemini Enterprise Agent Platform. The changes were announced at the Cloud Next 2026 conference. Forbes reported details on the associated Build, Scale, Govern and Optimize stack.